Scarica l'app Stockscreener
272.38
0.85%
2.29
Dopo l'orario di chiusura:
270.11
-2.27
-0.83%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CI Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$270.09
Aprire:
$268.9
Volume 24 ore:
1.58M
Relative Volume:
0.81
Capitalizzazione di mercato:
$72.76B
Reddito:
$268.22B
Utile/perdita netta:
$6.55B
Rapporto P/E:
12.02
EPS:
22.6688
Flusso di cassa netto:
$7.44B
1 W Prestazione:
-0.92%
1M Prestazione:
-1.49%
6M Prestazione:
-6.84%
1 anno Prestazione:
-10.05%
Intervallo 1D:
$265.75
$273.58
Intervallo di 1 settimana:
$265.75
$281.49
Portata 52W:
$239.51
$350.00
Cigna Group Stock (CI) Company Profile
Nome
Cigna Group
Settore
Industria
Telefono
(860) 226-6000
Indirizzo
900 COTTAGE GROVE ROAD, BLOOMFIELD, CT
Confronta CI con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CI
Cigna Group
|
272.38 | 72.15B | 268.22B | 6.55B | 7.44B | 22.67 |
|
UNH
Unitedhealth Group Inc
|
294.02 | 256.08B | 435.16B | 18.37B | 17.37B | 19.16 |
|
CVS
Cvs Health Corp
|
74.03 | 91.40B | 393.94B | 428.00M | 6.29B | 0.3826 |
|
ELV
Elevance Health Inc
|
341.85 | 71.77B | 194.82B | 5.53B | 3.77B | 24.45 |
|
HUM
Humana Inc
|
194.01 | 25.01B | 126.36B | 1.30B | 1.55B | 10.67 |
Cigna Group Stock (CI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-14 | Iniziato | Goldman | Buy |
| 2025-02-06 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2024-06-26 | Iniziato | Piper Sandler | Overweight |
| 2024-05-30 | Iniziato | Robert W. Baird | Outperform |
| 2024-03-06 | Iniziato | Barclays | Overweight |
| 2024-02-05 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2024-02-05 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-02-01 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2024-01-04 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2023-12-11 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-08-18 | Downgrade | Edward Jones | Buy → Hold |
| 2023-06-06 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2023-04-21 | Iniziato | Cantor Fitzgerald | Neutral |
| 2023-04-05 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2023-01-03 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-11-23 | Ripresa | Morgan Stanley | Overweight |
| 2022-11-21 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2022-07-14 | Downgrade | Jefferies | Buy → Hold |
| 2022-06-22 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2022-06-17 | Iniziato | Loop Capital | Hold |
| 2022-05-27 | Ripresa | Bernstein | Mkt Perform |
| 2022-05-26 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2022-05-16 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2022-05-09 | Aggiornamento | Cowen | Market Perform → Outperform |
| 2022-02-07 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-02-04 | Downgrade | Deutsche Bank | Buy → Hold |
| 2022-01-06 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2021-12-21 | Downgrade | JP Morgan | Overweight → Neutral |
| 2021-12-16 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-12-14 | Iniziato | Goldman | Neutral |
| 2021-11-17 | Iniziato | Seaport Research Partners | Buy |
| 2021-09-27 | Iniziato | SVB Leerink | Mkt Perform |
| 2021-09-10 | Downgrade | BofA Securities | Buy → Underperform |
| 2021-09-10 | Iniziato | Cowen | Market Perform |
| 2021-08-06 | Reiterato | BofA Securities | Buy |
| 2021-08-06 | Reiterato | Citigroup | Buy |
| 2021-08-06 | Reiterato | Deutsche Bank | Buy |
| 2021-08-06 | Reiterato | Jefferies | Buy |
| 2021-08-06 | Reiterato | Mizuho | Buy |
| 2021-08-06 | Reiterato | Oppenheimer | Outperform |
| 2021-08-06 | Reiterato | Truist | Buy |
| 2021-05-19 | Iniziato | Wells Fargo | Equal Weight |
| 2020-07-01 | Iniziato | SVB Leerink | Mkt Perform |
| 2020-05-04 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2020-03-24 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2019-12-11 | Downgrade | Wells Fargo | Market Perform → Underperform |
| 2019-10-18 | Iniziato | Mizuho | Buy |
| 2019-09-30 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2019-09-12 | Iniziato | Deutsche Bank | Buy |
| 2019-08-06 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2019-04-23 | Iniziato | UBS | Buy |
| 2019-01-14 | Iniziato | Stephens | Overweight |
| 2018-12-24 | Iniziato | Edward Jones | Buy |
| 2018-03-13 | Iniziato | Bernstein | Mkt Perform |
| 2018-03-08 | Iniziato | Barclays | Overweight |
| 2018-01-03 | Iniziato | Goldman | Neutral |
| 2017-11-03 | Reiterato | RBC Capital Mkts | Outperform |
| 2017-06-22 | Reiterato | RBC Capital Mkts | Outperform |
| 2017-06-12 | Iniziato | Credit Suisse | Outperform |
| 2017-06-07 | Iniziato | Morgan Stanley | Overweight |
| 2017-05-08 | Reiterato | RBC Capital Mkts | Outperform |
| 2017-04-05 | Iniziato | Deutsche Bank | Buy |
Mostra tutto
Cigna Group Borsa (CI) Ultime notizie
Insurance moves: CRC, Integrity and Pan-American Life Insurance - Insurance Business
Insurance moves at CRC, Integrity and Pan-American Life Insurance - Insurance Business
Celltrion drives record US Zymfentra prescriptions with broader coverageCHOSUNBIZ - Chosunbiz
Healthcare: Managed Care Stocks Plunge Following Almost-Flat Medicare Rate Proposal - Morningstar
The Cigna Group (CI) Shares Gap Down to $271.89 on Jan 27 - GuruFocus
Cigna Group $CI Shares Bought by Maj Invest Holding A S - MarketBeat
The Cigna Group (NYSE:CI) Stock Signal: Is the FTC Settlement Pause for Express Scripts a Buying Opportunity? - DailyForex
Cigna Group $CI Shares Sold by Vanguard Personalized Indexing Management LLC - MarketBeat
Compass Wealth Management LLC Acquires Shares of 16,715 Cigna Group $CI - MarketBeat
Cigna (CI) Faces Challenges with Proposed Medicare Rate Changes - GuruFocus
The Bull Case For Cigna Group (CI) Could Change Following FTC Pause Of PBM Case Proceedings - simplywall.st
Ending drug rebates will cost Cigna as much as $500M, CEO tells congressional panel - BenefitsPRO
Will FTC Settlement Pause for Express Scripts Reshape Cigna Group’s (CI) PBM-Driven Investment Narrative? - Yahoo Finance
Congress Grills Health Insurance CEOs With Hunterbrook Exposé - Hunterbrook
Cigna Group $CI Shares Sold by Resona Asset Management Co. Ltd. - MarketBeat
Cigna Group $CI Stock Position Raised by UniSuper Management Pty Ltd - MarketBeat
Strs Ohio Sells 9,232 Shares of Cigna Group $CI - MarketBeat
Commerzbank Aktiengesellschaft FI Has $5.01 Million Stock Position in Cigna Group $CI - MarketBeat
FTC Pause On Cigna PBM Case Highlights Valuation And Regulatory Risk - simplywall.st
Cigna Group $CI Shares Sold by AMF Tjanstepension AB - MarketBeat
The top health care trends for 2026 and how they will impact U.S. employers - Cigna Healthcare Newsroom
Can The Cigna Group be the next market leaderJuly 2025 Review & AI Enhanced Execution Alerts - mfd.ru
TrueMark Investments LLC Acquires Shares of 19,890 Cigna Group $CI - MarketBeat
Cigna Group (NYSE:CI) Cut to Hold at Wall Street Zen - MarketBeat
A Look At Cigna Group (CI) Valuation As Evernorth And Recession Narrative Draw Fresh Investor Interest - simplywall.st
FTC Delays Drug Middlemen Case While Talks Move Forward - Benzinga
US health insurance executives testify before Congress about increasing costs of healthcare - The Guardian
5 ways prioritizing preventive care can protect your health and your wallet - Cigna Healthcare Newsroom
Teacher Retirement System of Texas Purchases 21,839 Shares of Cigna Group $CI - MarketBeat
Bernstein Maintains Cigna Group(CI.US) With Hold Rating, Maintains Target Price $307 - 富途资讯
Insurance CEO hearings: Takeaways from a long day on Capitol Hill - Modern Healthcare
Cigna Group (NYSE:CI) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
RBC Capital Maintains Cigna Group(CI.US) With Buy Rating, Maintains Target Price $344 - 富途资讯
Cigna sees up to $600M earnings hit from ending drug rebates - Modern Healthcare News
Insurance CEO hearings: Execs endure criticism on costs, business practices - Modern Healthcare
Brian Evanko on affordable, personalized healthcare - McKinsey & Company
Health insurance CEOs grilled on high costs of care in back-to-back House hearings - NBC News
House Health Insurance - timesargus.com
Cigna Sees Up to $600 Million Earnings Hit From Pharmacy Plan - Bloomberg.com
Commercial health insurer CEOs testify on health care affordability; AHA submits statements for House hearings - American Hospital Association
Health insurance execs shift blame for costly, confusing health care system - statnews.com
Watch live: Health insurance CEOs testify before House on rising premiums - The Hill
US lawmakers press health insurance executives on affordability - Reuters
UNH and CVS Face Congress Over Healthcare Affordability - Barron's
March 6th Options Now Available For The Cigna Group (CI) - Nasdaq
Rakuten Investment Management Inc. Acquires New Stake in Cigna Group $CI - MarketBeat
UnitedHealth CEO Says Hospitals, Drug Prices Drive US Health Care Costs, Pledges ACA Rebates - Benzinga
Wealth Enhancement Advisory Services LLC Has $27.84 Million Stock Holdings in Cigna Group $CI - MarketBeat
Health insurance CEOs to appear before House committees as premiums soar - NBC News
FTC, Cigna weigh insulin settlement - Modern Healthcare
Birches Health Hires Ex-Cigna Leader as SVP of Strategy to Drive Payor-Integrated National Expansion - TipRanks
Cigna Group Azioni (CI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
5.86%
6.69%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):